Search the Newsreel

DXP Enterprises Inc 2026: Revenue $576.46M, EPS $1.76— 10-Q Summary

DXP Enterprises Inc reported strong financial results for the 2026 quarter, with revenue reaching $576.46M and diluted EPS at $1.76. This growth was attributed to organic expansion, recent acquisitions, and resilient margins. The company also saw significant growth in its Industrial Pipe & Supply …

DXP Enterprises Posts Strong Q2 Growth, Expands Canadian Water Business with Mequipco Acquisition

DXP Enterprises reported significant double-digit growth in Q2 sales and earnings, with sales increasing 15.6% to $576.5 million and net income rising 21.6% to $28.7 million. The company expanded its North American water infrastructure business by acquiring Mequipco Ltd., a Canadian supplier, establishing a …

DXP Enterprises (NASDAQ:DXPE) Hits New 12-Month High on Better-Than-Expected Earnings

DXP Enterprises (NASDAQ: DXPE) lifts H1 2026 revenue and cash flow

DXP Enterprises (DXPE) reported strong financial results for the second quarter and first half of 2026, with significant increases in sales, net income, and cash flow. The growth was primarily driven by strategic acquisitions and increased business activity across its Service Centers and Innovative …

Dxp Enterprises stock hits all-time high at 186.0 USD By Investing.com

DXP Enterprises Inc. stock has reached an all-time high of $186, reflecting a 74.29% increase over the past year and a 53% year-to-date return. Despite this strong performance, InvestingPro data suggests the stock may be overvalued with a P/E ratio of 32.19 and a …

CareDx, Inc. SEC Filing (Aug 5, 2026)

This article details a CareDx, Inc. (CDNA) SEC Filing on Form 144, dated August 5, 2026. The filing indicates a proposed sale of 20,000 shares of common stock by an individual who acquired them as compensation for past services in 2015, with an aggregate …

Dxc Technology Company Announces Appointment of Lisa Beaudoin to Chief Product Officer, Effective August 5, 2026

DXC Technology Company has announced the appointment of Lisa Beaudoin as Chief Product Officer, effective August 5, 2026. In her new role, Beaudoin will be responsible for leading a unified product development organization, overseeing product strategy, engineering, lifecycle management, and market execution across DXC's …

DXC partners with Primary on zero-trust security for enterprise AI

DXC Technology Co. has partnered with security startup Primary to offer exclusive managed services for Primary’s zero-trust platform, focusing on securing enterprise AI agents and applications. The solution governs how AI interacts with data by enforcing attribute-based access control and logging requests for compliance, …

DXC and Primary Launch AI-Native Zero Trust Platform for Enterprise AI

DXC becomes the exclusive managed services partner for Primary's AI-native Zero Trust Unified Control Plane, helping enterprises securely scale AI. New joint offering helps businesses and government agencies govern how AI agents and enterprise AI applications access data while strengthening security, identity, and compliance. …

MiMedx Group's (NASDAQ:MDXG) Soft Earnings Are Actually Better Than They Appear

MiMedx Group's recent earnings might seem weak, but a deeper analysis reveals a stronger financial position than initially perceived. The company's accrual ratio of -0.36 indicates that its free cash flow significantly exceeded its reported statutory profit, suggesting an understatement of its true earnings …

MiMedx Group Inc (MDXG) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for MiMedx Group Inc (MDXG), highlighting its current earnings forecast score of 8.00 and an average analyst price target of $12.00. Based on 5 analysts, the stock has a "Buy" rating with a potential upside of 61.29%. Key …

GeneDx Holdings Corp. (NASDAQ:WGS) Analysts Are Pretty Bullish On The Stock After Recent Results

Analysts are showing increased optimism for GeneDx Holdings Corp. (NASDAQ:WGS) after its latest second-quarter results, which saw revenues beat expectations and statutory losses narrow more than anticipated. Although revenue forecasts remain unchanged for the coming year, analysts have revised their loss per share predictions, …

DXP Enterprises: Q2 Earnings Snapshot

DXP Enterprises Inc. reported a Q2 profit of $28.7 million, with net income reaching $1.76 per share. The Houston-based industrial products supplier achieved revenues of $576.5 million for the period. This financial summary was generated using data from Zacks Investment Research.

DXP Enterprises, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:DXPE) 2026-08-06

Key Points Interested in DXP Enterprises, Inc.? Here are five stocks we like better. DXP Enterprises delivered strong Q2 growth: Sales rose 15.6% year over year to $576.5 million, while net income, diluted EPS and adjusted EBITDA increased; the EBITDA margin reached a company-record …

GeneDx (WGS) Stock Climbs On Strong Margins As Reimbursement Lags

GeneDx Holdings Corp. (WGS) saw its stock climb 4.8% after reporting strong Q2 2026 results, with exome and genome revenue reaching US$100.3 million and a gross margin of around 70%. The company achieved adjusted profitability ahead of schedule, demonstrating its core engine's efficiency. However, …

DXP Q2 2026 Earnings: Pumping Solutions Drives 15.6% Sales Growth

DXP Enterprises reported strong Q2 2026 earnings with sales up 15.6% to $576.5 million, primarily driven by its Innovative Pumping Solutions segment. GAAP diluted EPS rose to $1.76, and adjusted EBITDA increased significantly. The company's free cash flow also improved, though increased debt and …

DXP Posts Stronger Sales, Acquires Canadian Company

DXP Enterprises Inc. reported strong Q2 sales, increasing by over 15%, and earnings, up over 20%. The company also announced the acquisition of Mequipco Ltd., a Canadian water and wastewater mechanical equipment representative, providing DXP with an entry point into the Canadian market. This …

Planned 46,963-share sale reported by CDNA insider (CDNA)

A Form 144 notice for CareDx, Inc. (CDNA) indicates a proposed sale of up to 46,963 shares of common stock, valued at $2,178,945.34 as of August 5, 2026, through Morgan Stanley Smith Barney LLC. These shares originate from restricted stock grants and a stock …

Earnings Flash (DXPE) DXP Enterprises, Inc. Posts Q2 EPS $1.76

DXP Enterprises, Inc. reported its Q2 earnings per share (EPS) at $1.76. This announcement comes after the company also reported Q2 revenue of $576.5 million, surpassing FactSet's estimate of $543.0 million. The company's stock has seen significant changes, with a 5-day change of -1.53%, …

DXP Enterprises Acquires Mequipco to Expand Water Business

DXP Enterprises has acquired Canada's Mequipco, a specialist in mechanical equipment for water systems, to expand its water business into Western Canada. This acquisition, funded by cash and common stock, enhances DXP's market position and supports its strategy to grow water infrastructure products and …

DXP Enterprises earnings on deck: Can distributor deliver on Q2 momentum?

DXP Enterprises Inc. is scheduled to report its second-quarter results, with analysts expecting $1.57 EPS on $544.67 million revenue, a significant improvement over the first quarter's earnings miss. Investors will be closely watching if the company can validate management's assertion that the Q1 shortfall …

Price to sales forward of CareDx, Inc. – LS:A118WG

This article provides financial information for CareDx, Inc. (A118WG) from TradingView, focusing on its price to sales forward metric. It indicates that no trades were recorded and the market was closed. The content is primarily a data page with various links to other financial …

Press Release: DXP Enterprises, Inc. Announces Acquisition of Mequipco Ltd.

DXP Enterprises, Inc. has announced the acquisition of Mequipco Ltd., a Canadian distributor of rotating equipment, pumps, and process equipment. This strategic acquisition is expected to expand DXP's product offering and market presence in Western Canada, strengthening its position in the water and wastewater …

REG - Verici Dx PLC - Holding(s) in Company

Why CareDx (CDNA) Is Up 33.8% After Strong Q2 Profit, Higher 2026 Outlook And ESOP Shelf

CareDx reported strong Q2 2026 results with significant revenue and net income increases, leading to a 33.8% stock surge. The company raised its full-year 2026 revenue outlook to US$490 million–US$500 million and filed an US$80.30 million shelf registration for an employee stock ownership plan. …

MiMedx Group (MDXG) Holds Steady Near $4.24 as Consolidation Continues - Revenue Growth Stocks

GeneDx (NASDAQ:WGS) Shares Gap Up on Better-Than-Expected Earnings

GeneDx Holdings Corp (WGS) (Q2 2026) Earnings Call Highlights: Record Volume and Early ...

This article first appeared on GuruFocus. Total Revenue: $114.4 million, up 11% year-over-year. Exome and Genome Revenue: $100.3 million, up 17% year-over-year. Exome and Genome Test Volume: 30,785 tests, up 32% year-over-year. Gross Margin: 70%, up sequentially from 69% in the first quarter. Adjusted …

What To Expect From DXP’s (DXPE) Q2 Earnings

DXP Enterprises (DXPE) is expected to announce its Q2 earnings this Wednesday, with analysts projecting an 8.9% year-on-year revenue growth. The company missed revenue and EPS estimates last quarter, and its stock price has been unchanged over the last month, underperforming the maintenance and …

GeneDx Holdings (WGS) Is Up 9.7% After Beating Q2 Estimates And Reaffirming 2026 Outlook - Has The Bull Case Changed?

Genedx reaffirms 2026 revenue guidance of $475M-$490M while expecting meaningful collection-rate uplift starting in Q4

Earnings Call Insights: GeneDx Holdings Corp. (WGS) Q2 2026 MANAGEMENT VIEW * “We hit a new record, resulting more than 30,000 exome and genome tests in the quarter, which represents 32% year-over-year growth. We reported $114.4 million of total revenue, exceeding our guide, and …

[10-Q] GeneDx Holdings Corp. Quarterly Earnings Report

GeneDx Holdings Corp. (WGS) filed its quarterly earnings report (Form 10-Q) for the period ended June 30, 2026. The report details a new financing structure involving an amended loan agreement for an additional $50 million, increasing debt capacity to $150 million, and a conditional …

GeneDx Reports Second Quarter 2026 Financial Results

Reported second quarter 2026 revenue of $114.4 million, including $100.3 million in exome and genome revenue Reported exome and genome volume growth of 32% year-over-year Reported adjusted gross margin(1) of 70% and adjusted net income(1) of $0.4 million Reiterating full year 2026 revenue guidance …

DXC Q2 Deep Dive: AI Initiatives and Leadership Changes Shape Strategic Outlook

DXC Q2 Deep Dive: AI Initiatives and Leadership Changes Shape Strategic Outlook IT services provider DXC Technology (NYSE:DXC) met Wall Street's revenue expectations in Q2 CY2026, but sales fell by 5.1% year on year to $3.00 billion. On the other hand, next quarter's revenue …

DXC Technology Co. stock underperforms Monday when compared to competitors

DXC Technology Co. (DXC) stock fell 2.40% to $10.97 on Monday, underperforming the broader market, which saw the S&P 500 Index and Dow Jones Industrial Average rise. The company's stock closed 30.04% below its 52-week high of $15.68 reached in December.

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

Faruqi & Faruqi, LLP reminds investors of the August 3, 2026, deadline to seek lead plaintiff status in a federal securities class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS). The lawsuit alleges that GeneDx and its executives made false and misleading statements regarding …